CURE Childhood Cancer Annual Report 2013-2014

o u r 2 0 1 3 - 2 0 1 4 r e s e a r c h p r o j e c t s
A study to investigate the
A research study to
A study to identify the
biomarkers that determine
high-risk neuroblastoma
tumors and their
response to therapies,
particularly retinoic acid
(RA) in pediatric cancer
maintenance.
Dr. Kelly Goldsmith,
Aflac Cancer and Blood
Disorders Center of
Children’s Healthcare
of Atlanta
potential development
of MX69 as an effective
anti-tumor drug for
treating children suffering
from neuroblastoma.
Dr. Lubing Gu,
Aflac Cancer and Blood
Disorders Center of
Children’s Healthcare
of Atlanta
assess the feasibility
of developing drug
compounds into anticancer
treatment drugs
for pediatric cancer
patients with acute
lymphoblastic leukemia
(ALL).
Dr. Muxiang Zhou,
Aflac Cancer and Blood
Disorders Center of
Children’s Healthcare
of Atlanta
A continuing study
targeting aberrant
survival signaling in
high risk leukemia in
order to treat chemoresistant
tumors and
prevent future relapses.
Dr. Kevin Bunting,
Aflac Cancer and Blood
Disorders Center of
Children’s Healthcare
of Atlanta
CURE’s research decisions are guided by our Scientific Advisory Council
CURE’s Scientific Advisory Council (SAC) is a group of experts who review research proposals for
scientific merit and against the goals set by CURE’s Board of Directors. The SAC then makes funding
recommendations to the Board. Members include: Kevin L. Karem, PhD – Microbiologist, Council Chair;
Terry Ades, DNP, FNP-BC, AOCN – Director, Cancer Information, American Cancer Society; Carlos
Alvarado, MD – Emeritus Professor, Emory University; John D. Bergsagel, MD – Oncologist, Children’s
Healthcare of Atlanta and Assistant Professor of Pediatrics, Department of Pediatrics, Emory University
School of Medicine; Leon Bernal-Mizrachi, MD – Assistant Professor of Hematology and Medical
Oncology, Winship Cancer Institute of Emory University; William H. Chambers, PhD – Director, Clinical
Cancer Research and Immunology, American Cancer Society; Harry Findley, PhD – Emeritus Professor,
Emory University; Richard J. Woodcock, MD – Neuro-radiologist, MRI & Imaging of Georgia.
12